Da Xu
Impact in
- Transplantation top 5%
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Ubiquitin and proteasome pathways 4
- Oncology 18
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Ying Zhu (13 shared papers)Qiongzhu Dong (9 shared papers)Ze Zhang (8 shared papers)Baocai Xing (19 shared papers)Yan Zheng (7 shared papers)Lun–Xiu Qin (9 shared papers)Kun Wang (11 shared papers)Lu Lu (3 shared papers)
- Journals
- Cancer Cell International (4 papers)European Journal of Surgical Oncology (3 papers)Annals of Surgical Oncology (3 papers)Cancer Letters (2 papers)Cell Reports Medicine (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Da Xu
71 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 108
- Transplantation 97
- Hepatology 251
- Cancer Research 479
- Oncology 473
- Immunology 345
Countries citing papers authored by Da Xu
This map shows the geographic impact of Da Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Xu more than expected).
Fields of papers citing papers by Da Xu
This network shows the impact of papers produced by Da Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Xu. The network helps show where Da Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Da Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 342 | |
| 2 | 2020 | 331 | |
| 3 | 2019 | 125 | |
| 4 | 2020 | 93 | |
| 5 | 2022 | 72 | |
| 6 | 2018 | 61 | |
| 7 | 2020 | 58 | |
| 8 | 2024 | 50 | |
| 9 | 2018 | 49 | |
| 10 | 2018 | 49 | |
| 11 | 2016 | 48 | |
| 12 | 2020 | 47 | |
| 13 | 2019 | 46 | |
| 14 | 2020 | 45 | |
| 15 | 2023 | 44 | |
| 16 | 2018 | 38 | |
| 17 | 2023 | 36 | |
| 18 | 2017 | 36 | |
| 19 | 2021 | 33 | |
| 20 | 1993 | 32 |
About Da Xu
Da Xu is a scholar working on Molecular Biology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 74 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Ferroptosis and cancer prognosis (6 papers), Renal Transplantation Outcomes and Treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ubiquitin and proteasome pathways (4 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Transplantation (97 citations), Hepatology (251 citations), Cancer Research (479 citations), Oncology (473 citations) and Immunology (345 citations). Da Xu has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Ying Zhu, Qiongzhu Dong, Ze Zhang, Baocai Xing, Yan Zheng, Lun–Xiu Qin, Kun Wang, Lu Lu, Haiyi Gong and Jing Wang. Their work appears in journals such as Cancer Cell International, European Journal of Surgical Oncology, Annals of Surgical Oncology, Cancer Letters and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.